趋化性细胞因子受体-4,chemotaxis cytokine receptor-4
1)chemotaxis cytokine receptor-4趋化性细胞因子受体-4
1.Chapter one The expression and its meaning of stromal cell-derived factor-1αand chemotaxis cytokine receptor-4 in diabetic retinopathy and in diabetic cardiomyopathyObjective:To study the expression and its meaning of stromal cell-derived factor-1α(SDF-1α)and chemotaxis cytokine receptor-4 (CXCR-4)in diabetic retinopathy and in diabetic cardiomyopathy.第一章基质细胞衍生因子-1α及其受体CXCR-4在糖尿病大鼠视网膜病变和心肌病变中的表达及意义目的:研究糖尿病大鼠视网膜病变和糖尿病心肌病变中基质细胞衍生因子-1α(SDF-1α)及趋化性细胞因子受体-4(CXCR-4)和血管内皮生长因子(VEGF)的表达及意义。
2.Objective To evaluate the effects and mechanisms of stromal cell-derived factor-1α(SDF-1α) on the expression of chemotaxis cytokine receptor-4(CXCR-4) and vascular endothelial growth factor(VEGF) in bovine retinal microvascular endothelial cells(BRVEC) in vitro.目的观察基质细胞衍生因子-1α(stromal cell-derived factor-1α,SDF-1α)对体外培养的牛视网膜血管内皮细胞(bo-vine retinal vascular endothelial cells,BRVEC)表达趋化性细胞因子受体-4(chemotaxis cytokine receptor-4,CXCR-4)和血管内皮生长因子(vascular endothelial growth factor,VEGF)的影响,探讨SDF-1α对BRVEC作用的机制。
2)CXC chemokine receptor-4趋化性细胞受体因子4
1.Objective To investigate the expression of CXC chemokine receptor-4(CXCR4) and stromal-derived factor-1(SDF-1) in peripheral blood and pleural effusion of lung cancer patients and it′s clinical significance.目的探讨肺癌患者外周血、胸水以及肿瘤组织中骨髓基质细胞衍化生长因子(SDF-1)及其趋化性细胞受体因子4(CXCR4)的表达及其临床意义。
3)chemokine receptor趋化性细胞因子受体
1.Objective: To study the important role of Th2 cell chemokine receptor CCR4 in patients with atopic dermatitis.目的:为了研究异位性皮炎(atopic dermatitis,AD)患者皮损Th2型趋化性细胞因子受体CCR4在AD的发病过程中的作用。
2.Objective:To assess the important role of chemokine receptor CCR4 and CXCR3 in patients with atopic dermatitis.目的为研究特应性皮炎患者外周血趋化性细胞因子受体CCR4和CXCR3在特应性皮炎的发病过程中的作用。
3.AIM: To explore the role of chemokine receptor CXCR3 in pathogenesis of chronic hepatitis B.目的 :探讨趋化性细胞因子受体CXCR3在慢性乙型肝炎症发生机制中的作用。
英文短句/例句

1.CXC chemokine receptor 4 expression on CD4~+T lymphocytes are regulated by interleukin-4 and interleukin-10;白介素4与白介素10调控CD4+T细胞CXC趋化性细胞因子受体4的研究
2.Changes of the Natural Immuno-Function of Erythrocytes and the Erythrocyte Chemokine Receptor Binding Activity in Patients with Liver Cancer肝癌患者红细胞天然免疫与红细胞趋化因子受体结合活性的变化
3.The Study of Chemokine Fractalkine and Receptor CX3CR1 between Myocardial Ischemia and Reperfusion;趋化性细胞因子Fractalkine及受体CX3CR1与心肌缺血再灌注关系研究
4.Expression of chemokine receptors CX3CR1 mRNA in patients with systemic lupus erythematosus系统性红斑狼疮患者外周血单一核细胞CX3CR1趋化因子受体mRNA的表达
5.The Expression of CXC Receptor 4 in Prostate Neoplasm Cell;趋化因子CXC受体4在前列腺癌细胞中的表达
6.Expression and Significance of CXC Chemokine Receptor4 in Hepatocellular Carcinoma;趋化因子受体CXCR4在人肝癌细胞中的表达及意义
7.Experimental Study of the Expression of Chemokine Receptor CXCR4 in Colorectal Carcinomas Cell;结直肠癌细胞表达趋化因子受体CXCR4的实验研究
8.Effects of CXCR4 on Pulmonary Metastasis of Osteosarcomatous Cell Subline;趋化因子受体CXCR4对骨肉瘤细胞株肺转移的影响
9.Expression and Regulation of Chemokine Receptor 7 on T Cells in Patients with Psoriasis by Interleukin-18;白细胞介素18对银屑病T细胞趋化因子受体7表达调控的研究
10.Effect of chemokine receptor 7 (CXCR7) on proliferation, apoptosis and cycle of human breast cancer cell line MDA-MB-435s趋化因子受体CXCR7对人乳腺癌细胞生长、凋亡及细胞周期的影响
11.Expression of Stromal Cell-Derived Factor-1,Chemokine Receptor 4 and Vascular Endotheliar Growth Factor in Children with Wilms Tumor基质细胞衍生因子-1、趋化因子受体4及血管内皮生长因子在小儿肾母细胞瘤中的表达
12.Expression and clinical significance of chemokine receptor in peripheral blood mononuclear cells in patients with primary biliary cirrhosis原发性胆汁性肝硬化患者外周血单个核细胞趋化因子受体的表达及临床意义
13.Chemokine and chemokine receptor gene expression profiles of mouse hepatocellular carcinoma cell lines with differently metastatic potentials不同转移潜能小鼠肝癌细胞系趋化因子与受体基因表达谱的分析
14.Effects of Chemokine Receptor and Its Ligand on the Migration of Hepatocellular Carcinoma Cells;趋化因子受体CXCR4及其配体CXCL12在肝细胞癌转移中的研究
15.The Construction of Eukaryotic Expression Vector of Short Hairpin RNA for CXCR4 and Its Expression in Eukaryotic Cells;趋化因子受体CXCR4 shRNA真核表达载体的构建及其在真核细胞中的表达
16.vMIP-Ⅱ-induced Internalization and Regulation of Chemokine Receptor CXCR4 on the Surface of Cells;vMIP-Ⅱ对细胞表面趋化因子受体CXCR4内化及调变的研究
17.Activation of chemokine receptor CXCR4 promoted glioma stem cells migration and its mechanism趋化因子受体CXCR4活化促进人胶质瘤干细胞迁移及其机制探讨
18.The Effect of Erythrocyte Chemokine Receptor on the Relationship between Innate and Acquired Immunity in Patients with Psoriasis红细胞趋化因子受体在银屑病患者天然免疫和获得性免疫相关性中的作用
相关短句/例句

CXC chemokine receptor-4趋化性细胞受体因子4
1.Objective To investigate the expression of CXC chemokine receptor-4(CXCR4) and stromal-derived factor-1(SDF-1) in peripheral blood and pleural effusion of lung cancer patients and it′s clinical significance.目的探讨肺癌患者外周血、胸水以及肿瘤组织中骨髓基质细胞衍化生长因子(SDF-1)及其趋化性细胞受体因子4(CXCR4)的表达及其临床意义。
3)chemokine receptor趋化性细胞因子受体
1.Objective: To study the important role of Th2 cell chemokine receptor CCR4 in patients with atopic dermatitis.目的:为了研究异位性皮炎(atopic dermatitis,AD)患者皮损Th2型趋化性细胞因子受体CCR4在AD的发病过程中的作用。
2.Objective:To assess the important role of chemokine receptor CCR4 and CXCR3 in patients with atopic dermatitis.目的为研究特应性皮炎患者外周血趋化性细胞因子受体CCR4和CXCR3在特应性皮炎的发病过程中的作用。
3.AIM: To explore the role of chemokine receptor CXCR3 in pathogenesis of chronic hepatitis B.目的 :探讨趋化性细胞因子受体CXCR3在慢性乙型肝炎症发生机制中的作用。
4)Chemoattractant cell receptor-2趋化性细胞因子受体2
5)CCR9趋化性细胞因子受体9
6)ECKR红细胞趋化因子受体
1.Ouantitive Detection Erythrocyte Chemotatic Receptor (ECKR) with ABC-ELISA;ABC-ELISA定量测定红细胞趋化因子受体及其意义
2.To research the regularity of changes of RBC CD35 and ECKR in patients with carcinoma, studies of CD35 on red blood cells(RBC) using flow cytometry and ECKR and sIL 8 using ELISA were carried out in patients with carcinoma.采用流式细胞仪测定红细胞CD35 (RBC CD35 ) ,用免疫酶联法测定红细胞趋化因子受体 (ECKR) ,研究肿瘤患者红细胞CD35与趋化因子受体的变化规律。
延伸阅读

正常人白细胞转移因子 , 白细胞转移因子,转移因子药物名称:转移因子英文名:Transfer Factor别名: 正常人白细胞转移因子 , 白细胞转移因子,转移因子外文名:Transfer Factor ,TF适应症: 为细胞免疫反应增强剂,能将细胞免疫活性转移给受体,以提高受体的免疫功能。临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染(如带状皰疹、流行性乙型脑炎、白色念珠菌感染等)。对恶性肿瘤可作为辅助治疗剂,对自体免疫性疾病也有一定治疗作用。 用量用法: 一般采用皮下注射,注于上臂内侧或大腿内侧腹股沟下端,1次注射1支,每周1~2次,1个月后改为每2周1次。对带状疱疹,一般只需注射1次。 规格: 注射液:每支2ml,相当于1×1000000000白细胞提取物(上海产),北京产则相当于5~10×1000000000. 注:严禁静脉给药.类别:免疫调节剂